The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
of all universities in the world*
companies founded by graduates and faculty in the last 10 years
in Europe and #21 in the world for aerospace engineering*
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Antidote Health (opens in a new tab), one of several Israeli companies making healthcare affordable and accessible (opens in a new tab) in the United States, has teamed with the Charles Antetokounmpo Family Foundation (opens in a new tab) in the $1 million “Leave No One Behind” campaign to deliver free mental telehealth care services to residents of Milwaukee, Wisconsin.
“My family’s path to the United States wouldn’t have been possible without the kindness of others,” said Milwaukee Bucks basketball player Giannis Antetokounmpo, who is of Greek-Nigerian heritage.
“That’s why I’m delighted that CAFF and Antidote Health have come together to provide mental healthcare services to those in-need. It’s another great way we can give back to this community that has given us so much.”
Antidote Health Co-founder, Chairman, and President Ben Enosh is a Technion alumnus.
by
archive.israel21c.org (opens in a new tab)
on
March 20, 2023
Discover the collaboration between Antidote Health and Giannis Antetokounmpo to offer free mental healthcare in Milwaukee, Wisconsin.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Alumni /
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Prof. Hossam Haick of the Technion – Israel Institute of Technology, one of Israel’s most successful scientists, is really a frustrated karate fighter. As a boy in Nazareth, he joined a karate class and seemed to have found his calling. “I was incredibly competitive,” he says. “I went from one achievement to the next.” But […]
The Nobel Assembly at Karolinska Institutet announced Monday that professors Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Medicine, with two of the three laureates having received the Technion-Israel Institute of Technology Harvey Prize. Prof. Deisseroth of the Howard Hughes Medical Institute and Stanford University, USA, and Prof. Hegemann […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.